On July 28, Hunan held the 12th World Hepatitis Day theme publicity campaign. With the theme of “active prevention, active detection, and standardized treatment”, this event will promote the realization of the goal of eliminating hepatitis B transmission in Hunan Province by publicizing the knowledge of viral hepatitis prevention and treatment.
According to statistics, 86 million people in China are infected with hepatitis B virus (including 28 million people with hepatitis B), and 4.5 million people are infected with hepatitis C virus. People infected with hepatitis B and C viruses continue to develop liver cirrhosis and liver cancer, which seriously endangers the health of the Chinese people. Hepatitis is an inflammation of the liver. Viral hepatitis is divided into types A, B, C, D and E. Although the types of viruses are different, they are all enough to cause serious harm to people. Among them, hepatitis B and C can cause liver cirrhosis and liver cancer. occur, resulting in a serious global disease burden.
July 28, 2022 is the twelfth “World Hepatitis Day”. The event promoted health knowledge about hepatitis hazards, hepatitis infection routes, hepatitis preventive measures, etc., and called on everyone to take the initiative to get vaccinated , Take the initiative to check your health status.
Hefeng Li, director of the Health Education and Publicity Center of the Hunan Provincial Health and Health Commission, mentioned that for a long time, the public has misunderstood the disease and infection routes of viral hepatitis. It also affects the implementation of correct prevention and control strategies. To this end, he put forward three proposals, one is to strengthen health education and popularize health knowledge. The second is to improve ideological awareness and strengthen prevention capabilities. The third is to develop good habits and correct personal behavior.
Shenzhen Kangtai Biological Products Co., Ltd. is one of the earliest enterprises engaged in the production of recombinant hepatitis B vaccine (Saccharomyces cerevisiae). Lin Shuntao, general manager of the company in Hunan, said that the company has produced a total of 1.4 billion doses of hepatitis B vaccine, of which the self-developed 60μg hepatitis B vaccine is the first in the world and can help people with low or no response to produce effective antibodies.
A prize-based quiz, expert consultation and other activities were also carried out on the spot, and more than 400 promotional leaflets were distributed. The propaganda posters and exhibition boards about hepatitis prevention and control knowledge attracted community residents to stop and watch.
Xiaoxiang Morning News reporter Zeng Yuxuan and intern Zhang Chi
News clues reveal channel: Download the “Morning Video” client from the app market and enter the topic “Morning Help”; or call Chen Video Press hotline 0731-85571188.